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Objectives. We sought to examine the utilization of exercise
stress testing in relation to age and gender in a population-based
setting.
Background. The utilization of noninvasive procedures has
been shown to be associated with the subsequent use of invasive
procedures. Yet, there are no population-based data on the utiliza-
tion of stress testing; in particular, although gender differences in the
use of invasive procedures have been reported, the use of noninvasive
procedures has not been examined in relation to gender.
Methods. In Olmsted County, Minnesota, passive surveillance
of the medical care of the community is provided through the
Rochester Epidemiology Project. A population-based cohort of
Olmsted County residents undergoing exercise tests was identi-
fied. The medical records of residents with prevalent and incident
exercise tests in 1987 and 1988 were reviewed. For persons with an
initial test (incidence cohort), data on clinical presentation, test
indications and results were abstracted. Stress test utilization
rates were calculated, and crude rates were directly adjusted to
the age distribution of the 1980 U.S. population. To help interpret
patterns of use at the population level, coronary heart disease
mortality rates (International Classification of Diseases, 9th
revision, codes 410 to 414) were calculated (crude and directly
adjusted to the overall age distribution of the 1980 U.S. popula-
tion) and used as an indicator of coronary disease burden.
Results. A total of 2,624 tests were performed. The crude
utilization rate (per 100,000) was 1,888 for men and 703 for
women (rate ratio for men over women 2.7, 95% confidence
interval [CI] 2.5 to 2.9); it remained significantly higher in men
across all age strata. The crude incidence rate (per 100,000) of
initial stress tests was 1,112 for men and 517 for women (rate ratio
2.2, 95% CI 1.9 to 2.4). For both men and women, the incidence
increased with age; however, incidence remained lower in women
in all age strata. At the time that they underwent an initial test,
women were more symptomatic and had poorer exercise perfor-
mance than men. The rate ratio of men over women for coronary
heart disease mortality was 1.1 (95% CI 0.9 to 1.2). The age-
adjusted rate ratios for stress test utilization were 2.8 (95% CI 2.5
to 3.0), and that for coronary heart disease mortality was 1.9 (95%
CI 1.7 to 2.2).
Conclusions. These population-based data show that during the
study period, the utilization of stress testing in Olmsted County
was lower in women than in men. Women in the incidence cohort
were older and more symptomatic and had poorer exercise
performance than men. Such differences should be considered
when examining the utilization of subsequent invasive procedures
according to gender.
(J Am Coll Cardiol 1998;32:345–52)
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Despite a dramatic decline in overall cardiovascular mortality
(1,2), heart disease remains the leading cause of death for both
men and women in the United States (3). Some reports (1,2)
emphasize a slower rate of decline in mortality for women than
in men. The decline in mortality appears to have been favor-
ably influenced by the utilization of cardiovascular therapy (4),
yet several studies have shown (5–10) that invasive cardiac
procedures are used less frequently in women than in men. The
exact role of gender as an independent determinant of varia-
tion in health care delivery remains the subject of a consider-
able controversy (10–15). There is some evidence that women
are equally likely to undergo revascularization once they have
undergone coronary angiography (6,16).
Thus, the determining point in the advent of gender differ-
ences in the delivery of cardiac care would appear to occur at
an earlier phase in the sequence of care. Because the utiliza-
tion of invasive cardiac procedures is strongly related to the
use of stress test (17), it is crucial to examine the use of
noninvasive cardiac procedures according to gender to help
understand gender differences in the use of invasive proce-
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dures. Yet, comprehensive data on the use of stress testing at
the population level have not been reported. To measure
utilization rates, a population-based approach is needed. Ex-
amining this matter in a community setting has the added
important advantage of avoiding the potential biases inherent
to the studies of referral populations in tertiary care centers
(18–21). The present study takes advantage of the resources of
the Rochester Epidemiology Project to examine the utilization
of stress testing in a population-based setting in all age groups
and according to gender. It was designed to test the hypothesis
that there was no gender difference in the utilization rates of
stress testing in the population of Olmsted County Minnesota.
To help interpret the health care delivery patterns observed,
population-based mortality rates for coronary heart disease
were examined.
Methods
Study setting and cohort design. Epidemiologic research in
Olmsted County is possible because the county is relatively
isolated from other urban centers, and nearly all medical care
is delivered to local residents by a handful of providers. In
1990, census data indicated that the population was 96% white,
with 28% of the population .45 years old and 11% $65 years
old. With the exception of a higher proportion of the working
population employed in the health care industry, the charac-
teristics of the population of Olmsted County are similar to
those of U.S. whites.
Virtually all the medical care received by the Olmsted
County population is provided by the Mayo Clinic and the
Olmsted Medical Group and its affiliated Olmsted Community
Hospital. The epidemiologic potential of this situation is
enhanced by the fact that each provider uses a unit medical
record system, whereby all data collected for an individual
subject are assembled in one place. Thus, the details of every
inpatient and outpatient encounter can be accessed. The result
is the linkage of medical records from all sources of medical
care used by the Olmsted County population. These records
are easily retrievable because the Mayo Clinic has maintained,
since the early 1990s, extensive indexes based on clinical and
histologic diagnoses and surgical and billable procedures
(22,23).
The Rochester Epidemiology Project indexes, augmented
by the log books of the laboratories performing stress tests,
were used to identify a retrospective, population-based cohort
of Olmsted County residents who underwent an exercise stress
test between January 1, 1987 and December 31, 1988. This
time frame corresponds to a period during which there was
widespread and uniform use of a validated stress modality (i.e.,
exercise testing). Indeed, in Olmsted County during the time
frame of the study (1987 and 1988), exercise was essentially the
only stress modality in use: Only four dipyridamole stress tests
were performed in 1987 and nine in 1988. Focusing on the time
frame preceding the dispersion of stress tests modalities sup-
presses potential confounding of the gender differences in the
use of exercise stress tests by the availability of other stress
modalities. This time period allowed us to obtain coronary
disease mortality surveillance data in the community studied.
Finally, it provided the opportunity to analyze practice patterns
before the publication of the majority of the reports generating
concern over gender bias (6–10,13,24,25), precluding the in-
fluence of such publications.
Residency in Olmsted County in years 1987 and 1988 was
verified using information from birth certificates and city and
county directories. Residency on the index date and 1 year
before the index date were determined to identify anyone from
the cohort who may have moved to Olmsted County specifi-
cally to facilitate the diagnosis and treatment of conditions
associated with a stress test. Analyses included all persons
presenting for a stress test during the study period.
The prevalence cohort comprised all persons who under-
went an exercise stress test during years 1987 and 1988. The
incidence cohort comprised patients who underwent an initial
exercise stress test in 1987 and 1988, as identified through the
comprehensive review of the medical records. For these pa-
tients, data were collected to characterize patient demograph-
ics, presence, intensity, duration of clinical signs and symp-
toms, cardiovascular disease risk profile and comorbidity. Data
collection was carried out by a team of two experienced nurse
abstractors (V.L.R., S.J.J.) under direct supervision by the
primary investigator of the study.
To ensure the consistency of the abstraction process, each
abstractor reviewed independently the same sample of 20
records, and a sample of records already abstracted reviewed
was reviewed again by the same abstractor. Agreement be-
tween the two reviews for both intraabstractor and interab-
stractor variability was measured using kappa coefficients.
Variables yielding less than good agreement were entirely
reviewed.
The indications for the initial stress test were classified as 1)
evaluation of documented coronary disease defined by the
presence of any of the following three criteria: history of
myocardial infarction, coronary stenosis .50% by visual esti-
mate on coronary angiography before the stress test or previ-
ous coronary revascularization procedure (coronary artery
bypass graft surgery or angioplasty); 2) diagnostic if the patient
had any symptoms (dyspnea or chest pain) and did no indica-
tion of documented coronary disease; and 3) other if per-
formed in the absence of any symptoms and any documented
coronary disease.
The stress tests (treadmill exercise test, exercise radionu-
clide angiography or exercise thallium scintigraphy) were
considered positive according to conventional criteria, as pre-
viously reported. (26)
The existence of any comorbid condition was determined
Abbreviations and Acronyms
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through comprehensive review of the medical record. Comor-
bidities were recorded individually and were combined in a
validated summary measure of comorbidity (the Charlson
index [27]). The Charlson index is a weighted index of comor-
bidity that assigns weights for each condition present in a given
patient. This index has been used in studies based on medical
record review such as the present study and has also been
adapted for use with administrative databases (28). It is
strongly related to mortality independent of age.
Coronary heart disease mortality. To provide a benchmark
to assist in the interpretation of the observed population-based
rates of utilization of stress testing, coronary heart disease
mortality rates in Olmsted County were used as a measure of
the coronary disease burden at the population level. Death
tapes containing death certificate data from the Minnesota
Department of Health were obtained for Olmsted County
residents for years 1987 through 1993. The codes from the
ninth revision of the International Classification of Diseases
(ICD) that were used as indicators of coronary heart disease
mortality were as follows: 410 (acute myocardial infarction),
411 (other acute or subacute coronary heart disease), 412 (old
myocardial infarction), 413 (angina) and 414 (other forms of
chronic ischemic heart disease). These are the traditional
codes used in community surveillance studies (29).
Statistical analysis. Use of exercise stress tests. Utilization
and incidence rates were calculated as the numbers of exercise
stress tests divided by the Olmsted County population in 1987
and 1988 as derived by linear interpolation of census figures for
1980 and 1990 (30). The entire population of Olmsted County
was considered to be at risk for utilization rates. For incidence
rates, patients who had undergone stress testing before the
study period were no longer at risk for an incident test and thus
were removed from the denominators. Overall and age- and
gender-specific rates of use of exercise stress tests were calcu-
lated. The threshold of 65 years was also used to stratify the
rates. This stratification was performed to compare informally
the utilization of stress tests in Olmsted County with published
Medicare data. Confidence intervals around the point esti-
mates were calculated assuming a Poisson error distribution.
The rates were directly adjusted to the age distribution of the
1980 U.S. total population.
Among incident cases, comparisons between men and
women were made for a number of characteristics: age,
cardiovascular risk factors, clinical presentation at the time of
the initial stress tests and results of the stress test. The
frequencies of specific comorbid conditions were compared
across genders individually and combined using the Charlson
index. Bivariate associations with gender were tested with
chi-square tests for categoric data and t tests for continuous
variables.
Coronary heart disease mortality rates. Annual mortality
rates were calculated using coronary deaths as numerators; the
denominators were the Olmsted County population as derived
by linear interpolation of census figures for 1980 and 1990 (30).
Age- and gender-specific mortality rates were calculated.
The crude rates were directly adjusted using the 1980 U.S. total
population as the standard. Confidence intervals around the
point estimates were calculated assuming a Poisson error
distribution.
Results
Utilization. In 1987 and 1988, a total of 2,624 stress tests
were performed. The crude rate for men was 1,888/100,000,
and that for women was 703/100,000. The crude rate ratio for
men over women was 2.7 (95% confidence interval [CI] 2.5 to
2.9, p , 0.0001).
The age-specific utilization rates are displayed in Table 1.
The utilization rates were higher for men than women in all
age groups. With increasing age, the utilization rate ratios of
men to women tended to diminish, but exercise stress tests
were used nearly twice as frequently in men than in women
across all age strata. Among persons $65 years old, the
utilization rates were 1,699/100,000 (95% CI 1,473 to 1,925) for
women and 4,803/100,000 (95% CI 4,322 to 5,284) for men; the
rate ratio of men to women was 2.8 (95% CI 2.4 to 3.4, p ,
0.0001).
After adjustment, the utilization rates of stress tests were
2,068/100,000 (95% CI 1,971 to 2,165) for men and 746/100,000
for women (95% CI 692 to 801). The age-adjusted rate ratio
was 2.8 (95% CI 2.5 to 3.0, p , 0.0001). Among persons $65
Table 1. Utilization* of Stress Tests in Olmsted County, Minnesota, 1987 to 1988
Age
(yr)
Women Men
Men/Women Rate
Ratio (95 CI) p Value
No. of
Stress Tests Population Rate (95% CI)
No. of
Stress Tests Population Rate (95% CI)
0–19 0 31,454 0 (0–0) 8 32,447 25 (8–42) 0.0080
20–29 42 18,548 226 (158–295) 71 16,645 427 (328–526) 1.9 (1.3–2.8) 0.0009
30–39 99 18,734 528 (425–638) 312 18,352 1,700 (1,513–1,889) 3.2 (2.6–4.0) , 0.0001
40–49 133 12,787 1,040 (867–1,216) 430 12,426 3,460 (3,139–3,782) 3.3 (2.8–4.1) , 0.0001
50–59 156 8,689 1,795 (1,516–2,075) 480 8,718 5,506 (5,027–5,985) 3.1 (2.6–3.7) , 0.0001
60–69 177 6,763 2,617 (2,237–2,998) 386 5,871 6,575 (5,941–7,209) 2.5 (2.1–3.0) , 0.0001
70–79 113 5,322 2,123 (1,736–2,511) 161 3,403 4,731 (4,018–5,444) 2.2 (1.8–2.8) , 0.0001
801 28 4,041 693 (437–969) 28 1,508 1,857 (1,175–2,538) 2.7 (1.6–4.5) , 0.0001
Total 748 106,338 703 (653–754) 1876 99,370 1,888 (1,803–1,973) 2.7 (2.5–2.9) , 0.0001
*Includes all stress tests performed among local residents; each person was considered to be at risk. CI 5 confidence interval.
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years old, the age-adjusted rate ratio was 2.5 (95% CI 2.1 to
3.0).
Incidence. In 1987 and 1988, a total of 1,611 initial stress
tests were performed in 541 women and 1,070 men. The crude
rates for initial stress test were 1,112/100,000 for men and
517/100,000 for women. The corresponding crude rate ratio for
men over women was 2.2 (95% CI 1.9 to 2.4, p , 0.0001).
The age-specific incidence rates by gender are displayed in
Table 2. For both women and men, the incidence rates peaked
between ages 60 to 69 years, corresponding to 3% of the male
population and 1.7% of the female population in this age
stratum. The incidence rates were markedly higher in men in
all age groups, with the difference being statistically significant
in all strata.
After adjustment, the rate for men was 1,191/100,000 (95%
CI 1,116 to 1,266) and 548/100,000 (95% CI 501 to 595) for
women. The age-adjusted rate ratio was 2.2 (95% CI 2.0 to 2.4,
p , 0.0001).
Incidence cohort. Baseline characteristics. The baseline
characteristics among incident cases are summarized in Table
3. Women were older, more likely to be symptomatic (64% of
women reported either chest pain of dyspnea on exertion vs.
53% of men, p 5 0.001) and had a greater frequency of typical
as well as atypical chest pain. Consistent with this symptom
status, they were also more likely to be taking antianginal
medication. They were less likely to be smokers but more likely
to be hypertensive. The body mass index was greater in men
than in women. The frequency of diabetes mellitus was 4% in
both men and women. Women and men were equally likely to
have a history of myocardial infarction or heart failure.
Women were more likely to have peripheral or cerebrovascular
disease, but the magnitude of these differences was small.
However, there was no gender difference in the Charlson
index, which is a summary measure of comorbidities. Age
stratification did not reveal any gender difference in the
Charlson index.
Indications and results of the stress test. For both men and
women, the vast majority of the stress tests were treadmill
exercise tests, which reflects the practice in our community
during the study period. The indications for the exercise stress
test are summarized in Table 4. More women underwent stress
testing for diagnostic indications. With regard to exercise
performance, men exercised longer than women and to a
higher workload. They achieved a higher heart rate and systolic
blood pressure with exercise, resulting in a higher peak rate–
pressure product than women. These differences persisted
after stratification by age. There was a similar percentage of
positive tests in men and women.
Coronary heart disease mortality. The age- and gender-
specific coronary heart disease mortality rates for the Olmsted
County population in years 1987 through 1993 are shown in
Table 2. Incidence of Stress Tests in Olmsted County, Minnesota, 1987 to 1988
Age
(yr)
Women Men
Men/Women Rate
Ratio (95% CI) p ValueN Population Rate (95% CI) N Population Rate (95% CI)
0–19 0 31,448 0 (0–0) 8 32,440 25 (8–42) 0.0080
20–29 40 18,481 216 (149–283) 68 16,582 410 (313–507) 1.9 (1.3–2.8) 0.0011
30–39 90 18,483 487 (387–587) 267 18,006 1,483 (1,306–1,659) 3.1 (2.4–3.9) , 0.0001
40–49 108 12,492 865 (702–1,027) 280 11,694 2,394 (2,117–2,671) 2.8 (2.2–3.5) , 0.0001
50–59 105 8,311 1,263 (1,023–1,504) 214 7,844 2,728 (2,368–3,089) 2.2 (1.7–2.7) , 0.0001
60–69 110 6,385 1,723 (1,404–2,042) 156 5,124 3,044 (2,574–3,515) 1.8 (1.4–2.3) , 0.0001
70–79 69 5,044 1,368 (1,047–1,689) 61 3,044 2,084 (1,506–2,502) 1.5 (1.0–2.1) 0.0276
801 19 3,990 476 (263–690) 16 1,447 1,106 (567–1,645) 2.3 (1.2–4.5) 0.0103
Total 541 104,634 517 (474–560) 1,070 96,181 1,112 (1,046–1,179) 2.2 (1.9–2.4) , 0.0001
CI 5 confidence interval.
Table 3. Baseline Characteristics of Persons With an Incident Stress
Test, Olmsted County, Minnesota, 1987 to 1988, by Gender
Characteristic
Men Women p
(n 5 1,070) (n 5 541) Value
Age (yr) 48 6 14 53 6 16 , 0.0001
Symptoms
NYHA class III/IV 96 (9) 70 (13) 0.33
Typical angina 97 (9) 73 (14) 0.006
Atypical angina 144 (14) 118 (122) 0.001
Risk factors
Hx of smoking 564 (53) 213 (39) 0.001
Diabetes mellitus 45 (4) 23 (4) 0.97
Hypertension 253 (24) 157 (29) 0.019
Hyperlipidemia 518 (48) 281 (52) 0.18
Family Hx of CAD 434 (42) 244 (45) 0.2
Other clinical factors
BMI (kg/m2) 27.4 6 4.0 26.5 6 6 , 0.0001
Hx of MI 111 (10) 44 (8) 0.15
Hx of CHF 23 (2) 15 (3) 0.43
Hx of CABG/PTCA 88 (8) 25 (5) 0.007
PVD 40 (4) 30 (6) 0.09
CVD 16 (2) 19 (4) 0.009
Charlson index 0.49 6 1.15 0.59 6 1.21 0.16
Medication use
Antianginal agents 237 (22) 157 (29) 0.004
Estrogen replacement 0 94 (17.4) —
Data presented are mean value 6 SD or number (%) of patients. BMI 5
body mass index; CABG 5 coronary artery bypass grafting surgery; CAD 5
coronary artery disease; CHF 5 congestive heart failure; CVD 5 cerebrovascu-
lar disease; Hx 5 history; MI 5 myocardial infarction; NYHA 5 New York
Heart Association; PTCA 5 percutaneous transluminal coronary angioplasty;
PVD 5 peripheral vascular disease.
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Table 5. The crude rate was 143/100,000 for men and 132/
100,000 for women. The corresponding crude rate ratio was 1.1
(95% CI 0.9 to 1.2, p 5 0.21).
The age-adjusted rate was 197/100,000 (95% CI 180 to 214)
for men and 103/100,000 (95% CI 93 to 112) for women. The
age-adjusted rate ratio was 1.9 (95% CI 1.7 to 2.2).
Among persons $65 years old, the coronary heart disease
mortality rates were 975/100,000 (95% CI 885 to 1,065) for
women and 1,428/100,000 (95% CI 1,290 to 1,567) for men.
The crude rate ratio of men over women was 1.5 (95% CI 1.3
to 1.7, p , 0.0005), and the age-adjusted rate ratio was 2.0 (1.7
to 2.3).
Discussion
Gender differences in utilization of stress testing. To our
knowledge, the present study is the first to report age- and
gender-specific population-based rates of utilization of stress
testing. In addition, incidence rates (i.e., first-time use of a
stress test), which are useful to better understand the delivery
of care in the earlier phase of the patient evaluation, are
presented. During the study period, there was uniform use of
a single, well validated stress modality; our data therefore
represent the comprehensive experience of the community
during that time frame. Age-specific rates indicate that utili-
zation of stress tests increased with age to peak use in age
group 60 to 69 years and declined thereafter. Although stress
test use is intuitively perceived as being related to age, no data
have been published to support this perception, and no
gender-specific analysis of stress test use has been carried out,
thus not allowing for gender differences, if any, to emerge (17).
Gender-specific analyses reported in the present study
document, in a population-based setting, gender differences in
the utilization of exercise stress tests. After adjustment, exer-
cise stress tests were used almost three times as frequently in
men than in women, and the age-adjusted rate ratio of men
over women was highly significant. Because on average, coro-
nary disease affects women later in the course of their lives
than men, examination of utilization rates specific to older age
strata is also needed. Among persons $65 old, the time at
which detection of coronary disease is as clinically relevant a
question in women as in men, the overall utilization of stress
testing in men was still more than twice that in women. Age
adjustment within the 65 years and above strata only margin-
ally attenuated these gender differences.
Among persons in the incidence cohort, there were several
important differences between men and women. Consistent
with older age at onset of coronary disease (31,32), women
were older and were more likely to present with typical angina.
In addition, they had poorer exercise performance. Interest-
ingly, despite their more advanced age, their Charlson index
was not higher than that of men. Thus, among men and women
Table 4. Indications and Stress Test Results in Persons With an
Incident Stress Test, Olmsted County, Minnesota, 1987 to 1988,
by Gender
Men
(n 5 1,070)
Women
(n 5 541)
p
Value
Indication for ex stress test , 0.001
Diagnostic 40% 54%
Documented CAD 14% 10%
Other 46% 36%
Type of ex stress test 0.008
Treadmill 83% 77%
RNA 12% 15%
Thallium 5% 8%
Ex stress test results
Duration of ex test
(min)
11.7 6 4.1 9.4 6 4.3 , 0.001
Workload (METs) 10.4 6 3.7 8.03 6 3.3 , 0.001
Peak HR (beats/min) 159 6 28 153 6 28 0.0056
Ex SBP (mm Hg) 183 6 26 169 6 26 , 0.001
Peak RPP
(beats/min 3 mm Hg)
20,607 6 4,173 19,330 6 3,602 , 0.001
Positive test 12% 16% 0.139
Data presented are mean value 6 SD or percent of patients. Ex 5 exercise;
HR 5 heart rate; METs 5 metabolic equivalents; MI 5 myocardial infarction;
RNA 5 radionuclide angiography; RPP 5 rate–pressure product; SBP 5 systolic
blood pressure.
Table 5. Coronary Disease (International Classification of Diseases, 9th revision codes 410 to 414) Mortality Rates for Olmsted County
Residents for Years 1987 to 1993
Age
(yr)
Women Men Men/Women
Rate Ratio
(95% CI) p ValueN Population Rate (95% CI) N Population Rate (95% CI)
0–19 17 111,714 15 (8–22) 2 115,894 2 (0–4) 0.1 (0.0–0.4) 0.004
20–29 0 61,913 0 (0–0) 2 56,309 4 (0–8)
30–39 0 69,818 0 (0–0) 4 69,064 6 (0–11)
40–49 5 48,696 10 (1–19) 14 47,176 30 (14–45) 2.9 (1.1–8.5) 0.03
50–59 8 32,226 25 (8–42) 51 32,510 157 (114–200) 6.3 (3.2–14.0) , 0.0001
60–69 55 24,273 227 (167–286) 102 21,626 472 (380–563) 2.1 (1.5–2.9) , 0.0001
70–79 105 19,150 548 (444–653) 153 12,676 1,207 (1,017–1,397) 2.2 (1.7–2.8) , 0.0001
801 315 15,193 2,073 (1,847–2,300) 187 5,683 3,291 (2,827–3,754) 1.6 (1.3–1.9) , 0.0001
Total 505 382,983 132 (120–143) 515 360,938 143 (130–155) 1.1 (0.9–1.2) 0.21
CI 5 confidence interval.
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entering one major access pathway leading to invasive cardiac
evaluation, there is no measurable difference in comorbidity
despite older age, but women present with more symptoms
than men and use more medications.
Appropriateness of use of stress testing. The differential
use of stress testing between men and women observed in this
population-based setting raises the difficult question of its
appropriateness. Several points may be brought forth as a
potential explanation for such observed differences: 1) Uncer-
tainties about the diagnostic value of stress test in women,
which have been amply documented in published reports
(33–44) may account for part of these differences. It is of
interest to observe that in a population-based setting, when
women do undergo their first stress test, they have poorer
exercise performance than men. This poorer performance may
contribute to the lesser effectiveness of stress testing as a
clinical diagnostic tool in women. 2) One could speculate that
differences in access to health care between men and women
could contribute to such differences. This difference cannot be
totally excluded but is unlikely in a community where the
majority of persons have insurance coverage (45,46). 3) Gen-
der differences in the burden of disease evaluated with stress
testing could play a role in such differences in test utilization.
To address this question, a measure of the burden of coronary
heart disease at the population level is needed. Although there
is a general consensus that such burden differs according to
gender, the exact difference between men and women with
regard to the morbidity of coronary disease is actually difficult
to measure, particularly in an aging population (47). Myocar-
dial infarction incidence data, which are one source of such
information, are rare in published reports (48,49), and most of
the community surveillance programs that are designed to
provide reliable incidence data have an upper age limit of 74
years (4,50,51). This truncates the description of the disease
experience in women because coronary disease develops ;10
years later in women then in men. Cohort studies, including
population-based studies carried in Olmsted County, that
capture outpatient data have emphasized the difficulties with
regard to the definition of coronary disease in women because
of misclassification of chest pain, which is frequent in women
but may not represent ischemia (31,32,52).
Thus, coronary disease mortality emerges as one of the few,
albeit imperfect, resources to examine gender differences in
coronary disease experience. Although such comparisons can
only be informal, age-specific incidence rate ratios for stress
testing (Table 2) are lower than those for coronary heart
disease mortality (Table 5) across all age categories except for
age 80 and above. Age-specific coronary heart disease mortal-
ity figures from the Olmsted County population (Table 5)
clearly show that the coronary heart disease mortality differ-
ence between men and women greatly narrows with increasing
age.
The unadjusted analyses describe the experience of men
and women with regard to stress test use and coronary disease
mortality over their lifetimes. The crude (total) rates show a
disparity between genders in this regard. Whether this dispar-
ity reflects the greater age at which women experience coro-
nary disease, which in turn may lead to a lesser ability to
exercise, can only be speculative at this point and deserves
further study.
Adjustment of the utilization and coronary mortality rates
to the overall age distribution of the same population (U.S.
1980) also documented a greater disparity between genders in
the use of stress tests than that observed in coronary disease
mortality.
Thus, both crude and adjusted analyses indicate gender
inequality in the utilization of stress tests. Whether this
inequality reflects appropriate use, overutilization of stress
testing in men or underutilization in women is uncertain
because coronary disease mortality rates are an imperfect
benchmark. Future studies analyzing secular trends in coro-
nary disease incidence in relation to time trends in health care
delivery in the same population are needed to further explore
this issue.
Implications of lower use of stress testing in women.
Regardless of the interpretation of the health care delivery
patterns documented herein, such differences in stress test
utilization are important for the understanding of the use of
other downstream procedures. A strong association between
the intensity of diagnostic tests and the subsequent use of
invasive procedures has recently been reported (17,53). How-
ever, the intensity of the use of stress testing has not been
examined according to gender. Although published studies
present discordant results on the independent role of gender as
a predictor of health care delivery, there is some evidence that
once coronary anatomy is defined after coronary angiography,
gender does not play an independent role in the management
of patients (6,16).
This observation in turn prompts the question of the
existence of gender differences in utilization of stress tests, a
noninvasive procedure that often precedes coronary angiogra-
phy and is an important determinant of subsequent cardiac
care. Our data show gender differences in the use of stress
testing that persist after age adjustment. This finding supports
the assumption that gender differences in the use of stress tests
may play a role in the genesis of documented gender differ-
ences in the use of coronary angiography (5,6,9,10). This
assumption underscores the importance of examining the use
of stress tests as part of the analysis of the use of “downstream”
procedures when examining gender-specific delivery of cardiac
care.
Limitations of the study. One potential barrier to the
generalizability of these data is the pattern of health care
delivery in Olmsted County, which may not be representative
of the practice in other areas in the United States. However,
recent data on the use of stress tests in Medicare beneficiaries
from northern New England (17) indicated an annual utiliza-
tion rate of ;4% in 1992 and 1993, which is comparable to the
present data for men in this age category. In addition, the main
objective of the present study was to evaluate gender differ-
ences in health care delivery, and although regional variations
in health care delivery have been documented, there is no
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plausible reason to believe that the practice in Olmsted County
differs from other centers with regard to gender-specific pat-
terns of care. Because these data are population based and are
not subject to many of the referral or selection biases (18–21),
it may be possible to generalize these findings to populations
with a similar ethnic composition and socioeconomic status. It
is noteworthy that the access to health care that residents of
Olmsted County experience eliminates confounding due to
barriers to health care access, which is important in an analysis
of health care delivery.
Further studies in populations of different ethnic composi-
tion and socioeconomic status are needed to complement the
present one.
Conclusions. The present population-based data indicate
that the overall utilization of exercise stress tests in Olmsted
County, Minnesota, in 1987 and 1988 was higher in men than
in women. At the time that they underwent an initial test,
women were more symptomatic and had poorer exercise
performance than men. These differences should be consid-
ered when examining the utilization of subsequent invasive
procedures according to gender.
We acknowledge the dedicated help of Jeannie Hill and Susan Stotz for data
collection, Jill Killian for statistical analysis and Kristie Shorter for preparation
of the manuscript.
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